30th Apr 2009 12:14
United Drug plc ("United Drug" or the "Company")
30 April 2009
Director Declaration
Further to the announcement on 29 April 2009, regarding the appointment of Mr. Hugh Friel as a non-executive director of the Company, United Drug hereby notifies the following pursuant to paragraph 6.6.7 of the ISE Listing Rules and 9.6.13 of the UKLA Listing Rules:
(a) Mr Friel currently holds no directorships in any other publicly quoted company. In the last five years Mr. Friel was a director of Kerry Group plc.
(b) there are no details requiring disclosure for Mr. Friel under paragraph 6.6.7 (2) to (6) of the ISE Listing Rules or under paragraph 9.6.13 (2) to (6) of the UKLA Listing Rules.
In addition, in fulfilment of any obligation imposed by section 53 (1) of the Companies Act, 1990, Mr. Friel has notified the Company that he currently holds no ordinary shares and no share options over ordinary shares of 5c each in the share capital of the Company.
Ends
For reference:
Karen Geoghegan
Company Secretary
Tel: +353-1-4637720
About United Drug plc
United Drug is a leading international provider of services to healthcare manufacturers and pharmaceutical retailers, with operations in the UK, Ireland, Holland, Belgium and the USA. The Company has a long-term track record of delivering strong profit, earnings and dividend growth.
At the end of the 2008 financial year the Company announced the streamlining of its divisional structure into three new divisions (see overleaf). This allows for a better alignment of the businesses with the management and operating structure in the Group, improved communications throughout the Group and the delivery of synergies. The restructuring brings together all parts of the business involved in the delivery of healthcare products under one management and operating structure within a newly formed Healthcare Supply Chain division. The Group's packaging operations and speciality services will form a new Packaging & Speciality division and the contract sales business will continue to be reported as the Contract Sales & Marketing Services division.
In Healthcare Supply Chain, United Drug is the largest pharmaceutical wholesaler in the island of Ireland. It is also the market leader in contract distribution outsourcing (pre-wholesaling) in Ireland and has achieved the No. 1 position in the UK through its joint venture business UniDrug Distribution Group (UDG). The Company provides specials medicines manufacturing and distribution services in the UK. The Company also provides sales & marketing and technical service solutions, including contract distribution services to Medical & Scientific equipment & consumable manufacturers, with a market leading position in Ireland and an emerging presence in the UK.
In the Packaging & Speciality division United Drug is a leading international provider of pharmaceutical contract packaging services with facilities in the US, UK, Dutch and Belgian markets. The Company also provides speciality distribution services in the UK and Irish markets.
In the Contract Sales & Marketing Services division United Drug is a leading provider of contract sales outsourcing and related marketing services to pharmaceutical manufacturers in the UK, US and Ireland.
Related Shares:
UDG.L